March 21, 2022 Life Sciences Accounting & Reporting IntegriChain proudly sponsored the 2022 CBI Life Science Accounting and Reporting conference, where we discussed data-driven gross-to-net optimization and government pricing visibility. For a recording of our session, please fill out the form below. The CBI Life Science Conference was held March 21-30, 2022. Jen SharpeExecutive Director, Gross-to-Net Session Title: GTN and Pricing Visibility Session Description: Streamlining the process of gross-to-net and government price modeling is critical for specialty drugs that are entertaining new channel designs or facing increased pressure to contract. Manufacturers may need to model a change in contract terms, a change in channel strategy, or increases or decreases in patient support programs. For this, they require access to data for nearly any fee and price concession including channel service fees, patient support program utilization, and any rebate or administrative fee. Listen to industry leader Jennifer Sharpe, MBA and Kinneret Klein, Commercial Financial Planning and Analysis Director at Kyowa Kirin discuss best practices for sourcing the data needed for “what if” analytics, including channel service fees, patient support program utilization, and any rebate or administrative fee. Our latest whitepaper: The Case for GTN Automation, offers insights into the discussions between our industry experts and customers during the 2021 conference. For more solutions, case studies and information on our Gross-To-Net offering, click here.